The DOI matches its Crossref record; 130 of the 130 references it cites were found in a registry or an index.
Core–shell-type lipid–polymer hybrid nanoparticles as a drug delivery platform
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nanoparticle therapeutics: an emerging treatment modality for cancer
Davis, M. E., Chen, Z., & Shin, D. M. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2614 · Cited by 4,233
Solid lipid nanoparticles (SLN) for controlled drug delivery â a review of the state of the art
Müller, R. (2000) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(00)00087-4 · Cited by 3,759
Biodegradable nanoparticles for drug and gene delivery to cells and tissue
Panyam, J., & Labhasetwar, V. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00228-4 · Cited by 3,361
Olive, K. P., Jacobetz, M. A., Davidson, C. J., Gopinathan, A., McIntyre, D., Honess, D., Madhu, B., Goldgraben, M. A., Caldwell, M. E., Allard, D., et al. (2009) · Science · doi:10.1126/science.1171362 · Cited by 3,170
Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform
Hu, C.-M. J., Zhang, L., Aryal, S., Cheung, C., Fang, R. H., & Zhang, L. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1106634108 · Cited by 2,433
THE BIOCHEMISTRY OF P-GLYCOPROTEIN-MEDIATED MULTIDRUG RESISTANCE
Endicott, J. A., & Ling, V. (1989) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.58.070189.001033 · Cited by 2,071
(2016) · CRC Press eBooks · doi:10.1201/b12801 · Cited by 2,031
Molecular mechanisms of drug resistance
Longley, D., & Johnston, P. (2005) · The Journal of Pathology · doi:10.1002/path.1706 · Cited by 1,672
Freeze-drying of nanoparticles: Formulation, process and storage considerations
ABDELWAHED, W., DEGOBERT, G., STAINMESSE, S., & FESSI, H. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.09.017 · Cited by 1,611
Pharmacokinetics and Biodistribution of Nanoparticles
Li, S.-D., & Huang, L. (2008) · Molecular Pharmaceutics · doi:10.1021/mp800049w · Cited by 1,568
Nanoencapsulation I. Methods for preparation of drug-loaded polymeric nanoparticles
Pinto Reis, C., Neufeld, R. J., Ribeiro, & Veiga, F. (2006) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2005.12.003 · Cited by 1,354
Liposomes in drug delivery: Progress and limitations
Sharma, A. (1997) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(97)00135-x · Cited by 1,253
Structure and polymorphism of the hydrocarbon chains of lipids: A study of lecithin-water phases
Tardieu, A., Luzzati, V., & Reman, F. C. (1973) · Journal of Molecular Biology · doi:10.1016/0022-2836(73)90303-3 · Cited by 1,236
Formation of Solid-Supported Lipid Bilayers: An Integrated View
Richter, R. P., Bérat, R., & Brisson, A. R. (2006) · Langmuir · doi:10.1021/la052687c · Cited by 1,126
Self-Assembled Lipid−Polymer Hybrid Nanoparticles: A Robust Drug Delivery Platform
Zhang, L., Chan, J. M., Gu, F. X., Rhee, J.-W., Wang, A. Z., Radovic-Moreno, A. F., Alexis, F., Langer, R., & Farokhzad, O. C. (2008) · ACS Nano · doi:10.1021/nn800275r · Cited by 1,038
Govender, T. (1999) · Journal of Controlled Release · doi:10.1016/s0168-3659(98)00116-3 · Cited by 1,008
Dhar, S., Gu, F. X., Langer, R., Farokhzad, O. C., & Lippard, S. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809154105 · Cited by 994
Physical and chemical stability of drug nanoparticles
Wu, L., Zhang, J., & Watanabe, W. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.02.001 · Cited by 993
Temporal targeting of tumour cells and neovasculature with a nanoscale delivery system
Sengupta, S., Eavarone, D., Capila, I., Zhao, G., Watson, N., Kiziltepe, T., & Sasisekharan, R. (2005) · Nature · doi:10.1038/nature03794 · Cited by 945
Trends and Developments in Liposome Drug Delivery Systems
Lian, T., & Ho, R. J. Y. (2001) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.1023 · Cited by 907
PLGA–lecithin–PEG core–shell nanoparticles for controlled drug delivery
Chan, J. M., Zhang, L., Yuet, K. P., Liao, G., Rhee, J.-W., Langer, R., & Farokhzad, O. C. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2008.12.013 · Cited by 702
An overview of current delivery systems in cancer gene therapy
El-Aneed, A. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2003.09.013 · Cited by 693
Size-Dependent Immunogenicity: Therapeutic and Protective Properties of Nano-Vaccines against Tumors
Fifis, T., Gamvrellis, A., Crimeen-Irwin, B., Pietersz, G. A., Li, J., Mottram, P. L., McKenzie, I. F. C., & Plebanski, M. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.5.3148 · Cited by 664
siRNA delivery systems for cancer treatment
Oh, Y.-K., & Park, T. G. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.04.018 · Cited by 645
Engineering liposomes for drug delivery: progress and problems
Gregoriadis, G. (1995) · Trends in Biotechnology · doi:10.1016/s0167-7799(00)89017-4 · Cited by 626
Towards safe, non-viral therapeutic gene expression in humans
Glover, D. J., Lipps, H. J., & Jans, D. A. (2005) · Nature Reviews Genetics · doi:10.1038/nrg1577 · Cited by 598
Cationic lipids, lipoplexes and intracellular delivery of genes
Wasungu, L., & Hoekstra, D. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.06.024 · Cited by 595
Vitamin E TPGS as a molecular biomaterial for drug delivery
Zhang, Z., Tan, S., & Feng, S.-S. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.03.046 · Cited by 586
Barichello, J. M., Morishita, M., Takayama, K., & Nagai, T. (1999) · Drug Development and Industrial Pharmacy · doi:10.1081/ddc-100102197 · Cited by 539
Nanomedicine for targeted cancer therapy: Towards the overcoming of drug resistance
Shapira, A., Livney, Y. D., Broxterman, H. J., & Assaraf, Y. G. (2011) · Drug Resistance Updates · doi:10.1016/j.drup.2011.01.003 · Cited by 504
Chanan-Khan, A., Szebeni, J., Savay, S., Liebes, L., Rafique, N. M., Alving, C. R., & Muggia, F. M. (2003) · Annals of Oncology · doi:10.1093/annonc/mdg374 · Cited by 479
JIANG, W., GUPTA, R., DESHPANDE, M., & SCHWENDEMAN, S. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.09.003 · Cited by 478
Uziely, B., Jeffers, S., Isacson, R., Kutsch, K., Wei-Tsao, D., Yehoshua, Z., Libson, E., Muggia, F. M., & Gabizon, A. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.7.1777 · Cited by 477
Drug-loaded nanoparticles : preparation methods and drug targeting issues
Allémann, É., Gurny, R., & Doelker, É. (1993) · European Journal of Pharmaceutics and Biopharmaceutics · Cited by 454
Functional aliphatic polyesters for biomedical and pharmaceutical applications
Seyednejad, H., Ghassemi, A. H., van Nostrum, C. F., Vermonden, T., & Hennink, W. E. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.12.016 · Cited by 425
Szebeni, J., Muggia, F., Gabizon, A., & Barenholz, Y. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.06.017 · Cited by 423
Chemical stability of liposomes: implications for their physical stability
Grit, M., & Crommelin, D. J. A. (1993) · Chemistry and Physics of Lipids · doi:10.1016/0009-3084(93)90053-6 · Cited by 401
PEGylated liposomes elicit an anti-PEG IgM response in a T cell-independent manner
Ishida, T., Wang, X., Shimizu, T., Nawata, K., & Kiwada, H. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.05.015 · Cited by 382
Current methods for attaching targeting ligands to liposomes and nanoparticles
Nobs, L., Buchegger, F., Gurny, R., & Allémann, E. (2004) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20098 · Cited by 379
Evaluation of nanoparticle immunotoxicity
Dobrovolskaia, M. A., Germolec, D. R., & Weaver, J. L. (2009) · Nature Nanotechnology · doi:10.1038/nnano.2009.175 · Cited by 368
Wong, H. L., Bendayan, R., Rauth, A. M., Xue, H. Y., Babakhanian, K., & Wu, X. Y. (2006) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.101154 · Cited by 344
Liu, Y., Li, K., Pan, J., Liu, B., & Feng, S.-S. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2009.09.036 · Cited by 342
Valencia, P. M., Basto, P. A., Zhang, L., Rhee, M., Langer, R., Farokhzad, O. C., & Karnik, R. (2010) · ACS Nano · doi:10.1021/nn901433u · Cited by 335
(2024) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-031-52864-4 · Cited by 309
Wong, H. L., Rauth, A. M., Bendayan, R., Manias, J. L., Ramaswamy, M., Liu, Z., Erhan, S. Z., & Wu, X. Y. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-0282-x · Cited by 303
Factors affecting drug encapsulation and stability of lipid–polymer hybrid nanoparticles
Cheow, W. S., & Hadinoto, K. (2011) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2011.02.033 · Cited by 297
Mottram, P. L., Leong, D., Crimeen-Irwin, B., Gloster, S., Xiang, S. D., Meanger, J., Ghildyal, R., Vardaxis, N., & Plebanski, M. (2007) · Molecular Pharmaceutics · doi:10.1021/mp060096p · Cited by 296
Inflammasome-activating nanoparticles as modular systems for optimizing vaccine efficacy
Demento, S. L., Eisenbarth, S. C., Foellmer, H. G., Platt, C., Caplan, M. J., Mark Saltzman, W., Mellman, I., Ledizet, M., Fikrig, E., Flavell, R. A., et al. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.03.034 · Cited by 290
In Vitro and in Vivo mRNA Delivery Using Lipid-Enveloped pH-Responsive Polymer Nanoparticles
Su, X., Fricke, J., Kavanagh, D. G., & Irvine, D. J. (2011) · Molecular Pharmaceutics · doi:10.1021/mp100390w · Cited by 287
Polyethylene Glycol-Conjugated Copolymers for Plasmid DNA Delivery
Lee, M., & Kim, S. W. (2005) · Pharmaceutical Research · doi:10.1007/s11095-004-9003-5 · Cited by 277
Preparation and characteristics of monostearin nanostructured lipid carriers
Hu, F.-Q., Jiang, S.-P., Du, Y.-Z., Yuan, H., Ye, Y.-Q., & Zeng, S. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.01.040 · Cited by 269
A synthetic mimic of the secretory granule for drug delivery
Kiser, P. F., Wilson, G., & Needham, D. (1998) · Nature · doi:10.1038/28822 · Cited by 263
PLGA–PEI nanoparticles for gene delivery to pulmonary epithelium
Bivas-Benita, M., Romeijn, S., Junginger, H. E., & Borchard, G. (2004) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2004.03.008 · Cited by 256
Pancreatic Adenocarcinoma: The Actual 5-Year Survivors
Ferrone, C. R., Brennan, M. F., Gonen, M., Coit, D. G., Fong, Y., Chung, S., Tang, L., Klimstra, D., & Allen, P. J. (2008) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-007-0384-8 · Cited by 251
Salvador-Morales, C., Zhang, L., Langer, R., & Farokhzad, O. C. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.01.005 · Cited by 250
Polymer-Caged Lipsomes: A pH-Responsive Delivery System with High Stability
Lee, S.-M., Chen, H., Dettmer, C. M., O'Halloran, T. V., & Nguyen, S. T. (2007) · Journal of the American Chemical Society · doi:10.1021/ja070748i · Cited by 246
Vallhov, H., Qin, J., Johansson, S. M., Ahlborg, N., Muhammed, M. A., Scheynius, A., & Gabrielsson, S. (2006) · Nano Letters · doi:10.1021/nl060860z · Cited by 238
Freeze-drying of drug-free and drug-loaded solid lipid nanoparticles (SLN)
Schwarz, C., & Mehnert, W. (1997) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(97)00222-6 · Cited by 234
Akagi, T., Baba, M., & Akashi, M. (2011) · Advances in Polymer Science · doi:10.1007/12_2011_150 · Cited by 227
Bisht, S., Mizuma, M., Feldmann, G., Ottenhof, N. A., Hong, S.-M., Pramanik, D., Chenna, V., Karikari, C., Sharma, R., Goggins, M. G., et al. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0172 · Cited by 216
Hu, C.-M. J., Kaushal, S., Cao, H. S. T., Aryal, S., Sartor, M., Esener, S., Bouvet, M., & Zhang, L. (2010) · Molecular Pharmaceutics · doi:10.1021/mp900316a · Cited by 212
Song, X. R., Cai, Z., Zheng, Y., He, G., Cui, F. Y., Gong, D. Q., Hou, S. X., Xiong, S. J., Lei, X. J., & Wei, Y. Q. (2009) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2009.02.018 · Cited by 211
Wong, H. L., Bendayan, R., Rauth, A. M., & Wu, X. Y. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.09.007 · Cited by 207
Fang, R. H., Aryal, S., Hu, C.-M. J., & Zhang, L. (2010) · Langmuir · doi:10.1021/la103576a · Cited by 206
Steric Stabilization of Lipid/Polymer Particle Assemblies by Poly(ethylene glycol)-Lipids
Thevenot, J., Troutier, A.-L., David, L., Delair, T., & Ladavière, C. (2007) · Biomacromolecules · doi:10.1021/bm700753q · Cited by 198
Investigation of the gel formation of phospholipid-stabilized solid lipid nanoparticles
Westesen, K., & Siekmann, B. (1997) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(97)04890-4 · Cited by 198
Development of Biodegradable and Injectable Latices for Controlled Release of Potent Drugs
Gurny, R., Peppas, N. A., Harrington, D. D., & Banker, G. S. (1981) · Drug Development and Industrial Pharmacy · doi:10.3109/03639048109055684 · Cited by 197
Shi, J., Xiao, Z., Votruba, A. R., Vilos, C., & Farokhzad, O. C. (2011) · Angewandte Chemie International Edition · doi:10.1002/anie.201101554 · Cited by 196
Sah, H. (1999) · Journal of Controlled Release · doi:10.1016/s0168-3659(98)00148-5 · Cited by 187
Self-citationPEGylation: An Approach for Drug Delivery. A Review
Jain, A., & Jain, S. (2008) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v25.i5.10 · Cited by 186
Immunocompatibility and biocompatibility of cell delivery systems
Řı́hová, B. (2000) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00054-5 · Cited by 174
ElBayoumi, T. A., & Torchilin, V. P. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2392 · Cited by 170
Liu, Y., Pan, J., & Feng, S.-S. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.05.008 · Cited by 169
Colloidal systems for drug delivery: from design to therapy
Beija, M., Salvayre, R., Lauth-de Viguerie, N., & Marty, J.-D. (2012) · Trends in Biotechnology · doi:10.1016/j.tibtech.2012.04.008 · Cited by 163
Říhová, B. (1996) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(96)00404-8 · Cited by 162
An overview of lipid membrane supported by colloidal particles
Troutier, A.-L., & Ladavière, C. (2007) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2007.02.003 · Cited by 159
Carrillo‐Conde, B., Song, E.-H., Chavez-Santoscoy, A. V., Phanse, Y., Ramer‐Tait, A. E., Pohl, N. L. B., Wannemuehler, M. J., Bellaire, B. H., & Narasimhan, B. (2011) · Molecular Pharmaceutics · doi:10.1021/mp200213r · Cited by 147
Szebeni, J., Alving, C. R., Sávay, S., Barenholz, Y., Priev, A., Danino, D., & Talmon, Y. (2001) · International Immunopharmacology · doi:10.1016/s1567-5769(01)00006-6 · Cited by 147
Raghuvanshi, R. S., Katare, Y. K., Lalwani, K., Ali, M. M., Singh, O., & Panda, A. K. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00342-3 · Cited by 140
Anticancer activity of cisplatin-loaded PLGA-mPEG nanoparticles on LNCaP prostate cancer cells
Gryparis, E. C., Hatziapostolou, M., Papadimitriou, Ε., & Avgoustakis, K. (2007) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2006.12.017 · Cited by 139
Zhao, P., Wang, H., Yu, M., Liao, Z., Wang, X., Zhang, F., Ji, W., Wu, B., Han, J., Zhang, H., et al. (2012) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2012.03.004 · Cited by 138
Hybrid Nanocapsules: Interactions of ABA Block Copolymers with Liposomes
Ruysschaert, T., Sonnen, A. F. ‐., Haefele, T., Meier, W., Winterhalter, M., & Fournier, D. D. (2005) · Journal of the American Chemical Society · doi:10.1021/ja043600x · Cited by 137
Physical Adsorption of Bilayer Membranes on Silica
Rapuano, R., & Carmona‐Ribeiro, A. M. (1997) · Journal of Colloid and Interface Science · doi:10.1006/jcis.1997.5060 · Cited by 136
Zheng, Y., Yu, B., Weecharangsan, W., Piao, L., Darby, M. V., Mao, Y., Koynova, R. D., Yang, X., Li, H., Xu, S., et al. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.02.008 · Cited by 133
Intrinsic curvature in normal and inverted lipid structures and in membranes
Marsh, D. (1996) · Biophysical Journal · doi:10.1016/s0006-3495(96)79790-4 · Cited by 131
Gessner, A., Olbrich, C., Schröder, W., Kayser, O., & Müller, R. H. (2001) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(00)00639-6 · Cited by 127
The manufacturing techniques of drug-loaded polymeric nanoparticles from preformed polymers
Grabnar, P. A., & Kristl, J. (2011) · Journal of Microencapsulation · doi:10.3109/02652048.2011.569763 · Cited by 127
Hitzman, C. J., Elmquist, W. F., Wattenberg, L. W., & Wiedmann, T. S. (2006) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20591 · Cited by 119
Robust IgG responses to nanograms of antigen using a biomimetic lipid-coated particle vaccine
Bershteyn, A., Hanson, M. C., Crespo, M. P., Moon, J. J., Li, A. V., Suh, H., & Irvine, D. J. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.07.029 · Cited by 118
Physicochemical and Interfacial Investigation of Lipid/Polymer Particle Assemblies
Troutier, A., Delair, T., Pichot, C., & Ladavière, C. (2005) · Langmuir · doi:10.1021/la047659t · Cited by 112
Wang, A. Z., Yuet, K. P., Zhang, L., et al. (2010) · Nanomedicine · doi:10.2217/nnm.10.6 · Cited by 110
Wong, H. L., Rauth, A. M., Bendayan, R., & Wu, X. Y. (2006) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2006.10.022 · Cited by 109
LaNiO2: Synthesis and structural characterization
Crespin, M., Isnard, O., Dubois, F., Choisnet, J., & Odier, P. (2005) · Journal of Solid State Chemistry · doi:10.1016/j.jssc.2005.01.023 · Cited by 101
Messerschmidt, S. K. E., Musyanovych, A., Altvater, M., Scheurich, P., Pfizenmaier, K., Landfester, K., & Kontermann, R. E. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.03.010 · Cited by 100
Poly(amino acid)s: Promising enzymatically degradable stealth coatings for liposomes
Romberg, B., Metselaar, J. M., Baranyi, L., Snel, C. J., Bünger, R., Hennink, W. E., Szebeni, J., & Storm, G. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.11.018 · Cited by 98
Li, Y., Taulier, N., Rauth, A. M., & Wu, X. Y. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-9033-2 · Cited by 95
Clawson, C., Ton, L., Aryal, S., Fu, V., Esener, S. C., & Zhang, L. (2011) · Langmuir · doi:10.1021/la202123e · Cited by 94
Polymer-supported lipid shells, onions, and flowers
Bershteyn, A., Chaparro, J., Yau, R. G., Kim, M., Reinherz, E. L., Moita, L. F., & Irvine, D. J. (2008) · Soft Matter · doi:10.1039/b804933e · Cited by 92
Cuyper, M. D., & Joniau, M. (1991) · Langmuir · doi:10.1021/la00052a010 · Cited by 91
Immunogenicity and immunomodulatory properties of HPMA-based polymers☆
Říhová, B., & Kovář, M. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.10.005 · Cited by 90
Clinical translation of folate receptor-targeted therapeutics
Teng, L., Xie, J., Teng, L., & Lee, R. J. (2012) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2012.694863 · Cited by 89
Biological Evaluation of pH-Responsive Polymer-Caged Nanobins for Breast Cancer Therapy
Lee, S., Ahn, R. W., Chen, F., Fought, A. J., O’Halloran, T. V., Cryns, V. L., & Nguyen, S. T. (2010) · ACS Nano · doi:10.1021/nn100560p · Cited by 86
Sloat, B. R., Sandoval, M. A., Hau, A. M., He, Y. O., & Cui, Z. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.08.023 · Cited by 83
Heiati, H., Phillips, N. C., & TAWASHI, R. (1996) · Pharmaceutical Research · doi:10.1023/a:1016090420759 · Cited by 82
Stathopoulos, G., Boulikas, T., Vougiouka, M., Rigatos, S., & Stathopoulos, J. (2006) · Oncology Reports · doi:10.3892/or.15.5.1201 · Cited by 82
Bypassing multidrug resistance in human breast cancer cells with lipid/polymer particle assemblies
Jin, Y., Li, Jin, Y., Xie, Yao, Li, & Qiu (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s27864 · Cited by 70
Hitzman, C. J., Wattenberg, L. W., & Wiedmann, T. S. (2006) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20607 · Cited by 68
Troutier, A., Véron, L., Delair, T., Pichot, C., & Ladavière, C. (2005) · Langmuir · doi:10.1021/la050796l · Cited by 64
Interactions between bilayer membranes and latex
Carmona‐Ribeiro, A. M., & Lessa, M. D. M. (1999) · Colloids and Surfaces A Physicochemical and Engineering Aspects · doi:10.1016/s0927-7757(98)00532-9 · Cited by 61
Nanoparticles as Adjuvants for Vaccines
Kreuter, J. (1995) · Pharmaceutical biotechnology · doi:10.1007/978-1-4615-1823-5_19 · Cited by 58
Synthetic biomimetic supra molecular Biovector™ (SMBV™) particles for nasal vaccine delivery
von Hoegen, P. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00175-2 · Cited by 58
Yeh, M., Chang, W.-K., Tai, Y.-J., Chiang, C., Hu, C.-S., & Hong, P. (2011) · International Journal of Nanomedicine · doi:10.2147/ijn.s25646 · Cited by 57
Effect of the Polymer Nature on the Structural Organization of Lipid/Polymer Particle Assemblies
Thévenot, J., Troutier, A., Putaux, J., Delair, T., & Ladavière, C. (2008) · The Journal of Physical Chemistry B · doi:10.1021/jp805865r · Cited by 55
Pharmacokinetics and Biodistribution of LCP Nanoparticles
Liu, Y. (2012) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/f9nq-e261 · Cited by 54
Řı́hová, B. (1996) · Advanced Drug Delivery Reviews · Cited by 51
Optimization of DNA delivery by three classes of hybrid nanoparticle/DNA complexes
Zhong, Q., Chinta, D. M. D., Pamujula, S., Wang, H., Yao, X., Mandal, T. K., & Luftig, R. B. (2010) · Journal of Nanobiotechnology · doi:10.1186/1477-3155-8-6 · Cited by 50
EGFR Targeted PLGA Nanoparticles Using Gemcitabine for Treatment of Pancreatic Cancer
Aggarwal, S., Yadav, S., & Gupta, S. (2011) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2011.1238 · Cited by 49
Bathfield, M., Daviot, D., D’Agosto, F., Spitz, R., Ladavière, C., Charreyre, M., & Delair, T. (2008) · Macromolecules · doi:10.1021/ma801567c · Cited by 47
Biocompatibility and immunocompatibility of water-soluble polymers based on HPMA
Řı́hová, B. (2006) · Composites Part B Engineering · doi:10.1016/j.compositesb.2006.07.007 · Cited by 42
Phospholipid-assisted synthesis of size-controlled gold nanoparticles
He, P., & Zhu, X. (2006) · Materials Research Bulletin · doi:10.1016/j.materresbull.2006.10.014 · Cited by 41
Quality of life at the end of life: trends in patients with metastatic prostate cancer
MELMED, G. Y., Kwan, L. C., Reid, K. A., & Litwin, M. S. (2002) · Urology · doi:10.1016/s0090-4295(01)01457-1 · Cited by 41
Shi, J., Xiao, Z., Votruba, A. R., Vilos, C., & Farokhzad, O. C. (2011) · Angewandte Chemie · doi:10.1002/ange.201101554 · Cited by 41
Ueda, M., Iwara, A., & Kreuter, J. (1998) · Journal of Microencapsulation · doi:10.3109/02652049809006863 · Cited by 40
Grand Challenges in Modulating The Immune Response with RNAi Nanomedicines
Goldsmith, M., Mizrahy, S., & Peer, D. (2011) · Nanomedicine · doi:10.2217/nnm.11.162 · Cited by 35
Peyrot, M., Sautereau, A., Rabanel, J., Nguyen, F., Tocanne, J., & Samain, D. (1994) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(94)90036-1 · Cited by 31
Preclinical Development for Suspensions
Garad, S., Wang, J., Joshi, Y. M., & Panicucci, R. (2009) · Springer eBooks · doi:10.1007/978-1-4419-1087-5_5 · Cited by 17
Lipids of membranes: Chemistry, biological role and applications as drug carriers
Hatziantoniou, S., & Demetzos, C. (2008) · Studies in natural products chemistry · doi:10.1016/s1572-5995(08)80027-0 · Cited by 17
Adsorption of plasmid DNA onto lipid/polymer particle assemblies
Troutier, A., Thévenot, J., Delair, T., & Ladavière, C. (2009) · Soft Matter · doi:10.1039/b911260j · Cited by 16
PEGylation: An Overview and Recent Advances Reported in the Patent Literature
González, M., Vaillard, S. E., & Grau, R. J. A. (2011) · Recent Patents on Chemical Engineering · doi:10.2174/1874478811104030241 · Cited by 8
Lipid-coated biodegradable particles as “synthetic pathogens” for vaccine engineering
Bershteyn, A., Chaparro, J., Riley, E. B., Yao, R. S., Zachariah, R. S., & Irvine, D. J. (2009) · IEEE Annual Northeast Bioengineering Conference (NEBEC) · doi:10.1109/nebc.2009.4967679 · Cited by 3
Cited by
Polymeric Nanoparticles for Drug Delivery
Beach, M. A., Nayanathara, U., Gao, Y., Zhang, C., Xiong, Y., Wang, Y., & Such, G. K. (2024) · Chemical Reviews · doi:10.1021/acs.chemrev.3c00705 · Cited by 1,155
Lipid–polymer hybrid nanoparticles as a new generation therapeutic delivery platform: A review
Hadinoto, K., Sundaresan, A., & Cheow, W. S. (2013) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2013.07.002 · Cited by 702
Nanomaterials in Targeting Cancer Stem Cells for Cancer Therapy
Qin, W., Huang, G., Chen, Z., & Zhang, Y. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00001 · Cited by 656
Mukherjee, A., Waters, A. K., Kalyan, P., Achrol, A. S., Kesari, S., & Yenugonda, V. M. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s198353 · Cited by 493
Nanoparticles for drug delivery to the anterior segment of the eye
Janagam, D. R., Wu, L., & Lowe, T. L. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.04.001 · Cited by 341
Metadata
- Authors
- Mandal, B., Bhattacharjee, H., Mittal, N., Sah, H., Balabathula, P., Thoma, L. A., & Wood, G. C.
- Venue
- Nanomedicine: Nanotechnology, Biology and Medicine
- Publisher
- Elsevier BV
- Published
- 2013-05
- Volume
- 9
- Issue
- 4
- Pages
- 474-491
- ISSN
- 1549-9634 (ISSN-L)
- OpenAlex
- W2001603955
- Cited by
- 467
- References
- 130
- FWCI
- 6.37
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.